Pancreatic Cancer North America

Pancreatic Cancer North America

Non-profit Organizations

Manhattan, NY 98 followers

Pancreatic Cancer North America funds innovative research to raise survival rates.

About us

Pancreatic Cancer North America (formally PancONE Network Inc.) aims to disrupt the traditional approach to discovery in pancreatic cancer by bringing together multiple sectors, innovations, and novel methods to drive real change. Pancreatic cancer is known as the world’s toughest cancer. Over the past 50 years, we’ve seen only marginal improvements in survival and yet it remains one of the most overlooked and underfunded cancers. Pancreatic Cancer North America, together with our partners at Pancreatic Cancer Canada, have decided that enough is enough. We’ve raised enough sympathy – it is time to raise survival rates.

Industry
Non-profit Organizations
Company size
2-10 employees
Headquarters
Manhattan, NY
Type
Nonprofit
Founded
2020
Specialties
pancreatic cancer, research, fundraising, charity, health promotion, advocacy, support services, community engagement, non-profit, cancer awareness, and cancer prevention

Locations

Updates

  • During #FireFighterCancerAwarenessMonth we must acknowledge that cancer is an urgent health risk our first responders are faced with. Over 94% of line-of-duty deaths are caused by occupational cancers, including pancreatic cancer. This alarming statistic underscores the importance of early detection, our greatest ally against this disease. By recognizing the signs and symptoms, wearing proper protective gear, and staying informed, we can help protect fire fighters from the world's toughest cancer. Learn more and find downloadable resources on our website: https://lnkd.in/gp335pvv

    • No alternative text description for this image
  • As we recognize #FireFighterCancerAwarenessMonth, our thoughts are with those currently fighting the wildfires spreading across Los Angeles. This tragedy is a prime example of why we have made it a priority to advocate for and support fire fighters. While they fight for our lives, we must continue to advocate for their health and wellbeing as they face an increased risk of cancer. Learn more about our work to support fire fighters and their loved ones on our website: https://lnkd.in/gr_eB4UN

    • No alternative text description for this image
  • As we welcome 2025, we are determined to make this a year of change and progress for those impacted by pancreatic cancer. With rising diagnoses in younger generations and alarmingly low survival rates, it’s clear that change is urgently needed. We need your support to drive research, increase awareness, and demand the action needed to shift the course of this disease. Together, we can make a difference.

    • No alternative text description for this image
  • As the holiday season approaches, we hope you find moments of peace, warmth, and connection with those who matter most to you. This time of year can bring both joy and challenges, but know that you are surrounded by a community that cares deeply and stands by your side. Happy holidays from all of us at Pancreatic Cancer North America. May the spirit of togetherness carry you through this holiday season and into the new year ahead.

    • No alternative text description for this image
  • Early detection of pancreatic cancer can mean the difference between life and death, but diagnosing it in its early, more treatable stages remains a significant challenge. That’s why we are proud to invest in Dr. Eugene Koay’s innovative research project to address this challenge by using AI to combine diagnostic imaging and blood-based biomarkers. In our latest blog post, Dr. Koay shares what makes the study unique and its potential for identifying new methods for diagnosing pancreatic cancer at earlier stages. Read more on our blog: https://lnkd.in/gqUxE8az

    • No alternative text description for this image
  • "The real issue isn’t whether it’s possible to improve outcomes – it’s that we haven’t yet prioritized pancreatic cancer enough to make it happen." Our CEO, Michelle Capobianco recently spoke to the Union for International Cancer Control (UICC) about the importance of early detection and how it can lead us out of the global pancreatic cancer crisis we're currently facing. Read more through the link below: https://bit.ly/3ZzNzi9

    With a five-year survival rate of just 13%, the need for early detection and innovative research has never been more urgent. Michelle Capobianco, CEO of Pancreatic Cancer North America, highlights the critical importance of increasing funding and prioritising research to improve early detection and treatment options. Drawing from successes in other cancers like breast and prostate, Michelle believes that with the right focus, we can change the narrative for pancreatic cancer. https://bit.ly/3ZzNzi9

    • No alternative text description for this image
  • The FDA has granted accelerated approval to zenocutuzumab-zbco (Bizengri) for patients with advanced pancreatic cancer harboring an NRG1 gene fusion. This news is especially exciting given it's the first systemic therapy of its kind for this gene group. For a disease with a survival rate of just 13%, this news represents more than just a treatment; it's a step toward giving patients more time and a better quality of life, while underscoring the importance of continued investment in bold solutions for this disease. Read more: https://bit.ly/4fu5BZn

    • No alternative text description for this image
  • #GivingTuesday is a global movement to do better for each other through acts of generosity. This year, it comes during a global pancreatic cancer crisis - the number of people diagnosed with pancreatic cancer is increasing each year, but the survival rate has not improved beyond 10%. Your gift can help us to collectively demand better for pancreatic cancer patients and their families. Every donation made between today and the end of December will be matched (to a maximum of $20,000). Give today: https://lnkd.in/ddCxeCDY

    • No alternative text description for this image
  • As #PancreaticCancerAwarenessMonth comes to a close, we are reflecting on the stories shared throughout November. Dan, Sarah, and many others shined a light on the human impact of pancreatic cancer with stories of grief, hope, and determination for change. Your voices will continue to drive our mission to raise awareness, increase early detection, and improve survival rates. With every story shared, every dollar raised, and every conversation sparked, we’re building momentum towards a future where pancreatic cancer is not only treatable, but survivable. Thank you for showing us that together, we can do more.

    • No alternative text description for this image

Similar pages